“david-liu” Archives

in
Entry Author Date Location
Laurie Glimcher To Headline Xconomy Keynote Series in Boston in September 05/16/19 Boston
Beam Brings In $135M to Turn CRISPR Base Editing into Drugs 03/06/19 Boston
Pursuing a “Crazy, Stupid” Idea & Photos From Disruptors in Boston 10/25/18 Boston
Xconomy Awards 2018 Gala Honors the Best of Boston Life Science: Slideshow 10/11/18 Boston
Catch CRISPR 2.0, RNA-Targeting Drugs & More At “Disruptors” on Oct. 17 09/26/18 Boston
Agenda Posted for Boston’s Life Science Disruptors on Oct. 17 09/10/18 Boston
The Winners of the 2018 Xconomy Awards Are… 09/05/18 Boston
Beam, Celsius & Arrakis at Boston’s Life Science Disruptors Oct. 17 08/27/18 Boston
Precision Tinkering of Cells, Genes & Microbes: The Big Idea Finalists 07/30/18 Boston
The 2018 Xconomy Awards Finalists Are… 06/28/18 Boston
Beam Therapeutics Spotlights CRISPR 2.0 with Precise Gene Editor, $87M 05/14/18 Boston
CRISPR Could Soon Charge into Hearing Loss Drug Race, New Study Suggests 12/20/17 National
Intrigue and Outdated Rules Complicate Big Biotech Patent Fight 12/16/14 National
Katrine Bosley, Former Avila CEO, Takes Helm at Editas 06/24/14 Boston
Three VCs Pour $43M Into Editas to “Edit” Out Genetic Disorders 11/25/13 Boston
Ensemble Signs Pact with Boehringer Worth up to $186 million 11/01/12 Boston
Founders Fund-Backed Knewton And Other Education-Tech Companies Move to the Head of the Class 10/19/11 New York
Ensemble Therapeutics Builds Super-Sized Library of Mid-Sized Drugs 07/19/11 Boston
In Seed Funding Race, AngelList Sorts the “Junk” from the “Maybes” 08/20/10 San Francisco
Ensemble Discovery Nabs Second Partner, Pfizer, to Develop New Class of Therapies 01/06/10 Boston
Ensemble Nails Deal with Bristol-Myers Squibb to Discover New Drugs 04/15/09 Boston
Personalized Treatments for Cancer: Ensemble Moves Ahead with Roche on New Breed of Test 11/12/08 Boston
Page 1 of 1